NEPHROPLUS

Nephrocare Health Services Ltd.

671.95-3.0 (-0.44%)
3 Jul, 3:30 PM

Annual Reports and Financial Documents

Nephrocare Health Services Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2026
Annual Reports
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Nephrocare Health Services Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • General25 Jun 2026
    Issuance Of Corporate Guarantee And Standby Letter Of Credit Facilities
    This is to inform that the Company has issued a Corporate Guarantee and provided collateral/security support as per the details annexed disclosed herewith.
  • Memorandum of Understanding /Agreements25 Jun 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Pursuant to Reg 30 of SEBI LODR Regulations, 2015, we hereby inform that Nephrocare Health Services, philippines Inc., overseas step-down wholly owned subsidiary of the company has acquired ....
  • Memorandum of Understanding /Agreements23 Jun 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Pursuant to Reg 30 of SEBI LODR Regulations, 2015, we hereby inform that Nephrocare Health Services, Philippines Inc., overseas step-down wholly owned subsidiary of the company has acquired ....
  • General22 Jun 2026
    Disclosure Under Regulation 30 - Approval Of Nephroplus Employee Stock Option Scheme 2026.
    Pursuant to Regulation 30 of SEBI LODR, 2015, we hereby inform you that the Company has approved the NephroPlus Employee Stock option scheme 2026 in the Board meeting held on June 22, 2026 ....
  • Closure of Trading Window19 Jun 2026
    Closure of Trading Window
    Trading window shall be closed till 48 hours from the declaration of the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
  • General17 Jun 2026
    Cancellation Of Scheduled Analyst / Institutional Investor Meetings
    In reference to our letter dated May 27, 2026, regarding Analyst Meet has now been cancelled due to unavoidable exigencies as per disclosure annexed herewith.
  • Analyst / Investor Meet11 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.
  • Memorandum of Understanding /Agreements10 Jun 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Pursuant to Reg 30 of SEBI LODR Regulations, 2015, we hereby inform that Nephrocare Health Services, Philippines Inc., overseas step-down wholly owned subsidiary of the company has acquired ....
  • Memorandum of Understanding /Agreements4 Jun 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Pursuant to Reg 30 of SEBI LODR Regulations, 2015, we hereby inform that Nephrocare Health Services, Philippines Inc., overseas step-down wholly owned subsidiary of the company has acquired ....
  • Analyst / Investor Meet27 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.
  • Analyst / Investor Meet27 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith
  • Acquisition26 May 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Pursuant to Reg 30 of SEBI LODR Regulations, 2015, we hereby inform that Nephrocare Health Services International Pte. Ltd, overseas wholly owned subsidiary of the Company has incorporated ....
  • Analyst / Investor Meet26 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.
  • Analyst / Investor Meet26 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.
  • Memorandum of Understanding /Agreements26 May 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Pursuant to Reg 30 of SEBI LODR Regulations, 2015, we hereby inform that Nephrocare Health Services, Philippines Inc., overseas stepdown wholly owned subsidiary of the Company has acquired ....
  • Analyst / Investor Meet22 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call on Tuesday, June 2, 2026 at 11:00 AM (Indian Standard Time).
  • Analyst / Investor Meet20 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    In continuation to our letter dated May 04, 2026, please find enclosed link of the audio recording of the Investors' Conference Call held on May 20, 2026 on the Audited Standalone and Consolidated ....
  • General19 May 2026
    Re-Appointment Of Internal Auditor
    The Board of Directors at its meeting held on May 19, 2026 has re-appointed M/s. BDO India LLP as Internal Auditor as per the disclosure annexed herewith.
  • General19 May 2026
    Issuance Of Corporate Guarantee
    This is to inform you that the Board of Directors in its meeting held on has approved and granted in-principal approval for providing corporate guarantee as per the disclosure annexed herewith.
  • Press Release / Media Release19 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release on Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026.

Frequently Asked Questions

Where can I download the annual report of Nephrocare Health Services Ltd.?
Annual reports of Nephrocare Health Services Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Nephrocare Health Services Ltd.?
Quarterly earnings results and presentations of Nephrocare Health Services Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Nephrocare Health Services Ltd. publish earnings call transcripts?
Earnings call transcripts of Nephrocare Health Services Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Nephrocare Health Services Ltd.?
Investor presentations and annual day presentations of Nephrocare Health Services Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Nephrocare Health Services Ltd.?
Corporate announcements and regulatory filings of Nephrocare Health Services Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Nephrocare Health Services Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Nephrocare Health Services Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Nephrocare Health Services Ltd.?
The ISIN (International Securities Identification Number) of Nephrocare Health Services Ltd. is INE428V01029. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Nephrocare Health Services Ltd. listed?
Nephrocare Health Services Ltd. is listed on NSE and BSE. The NSE symbol is NEPHROPLUS and the BSE code is -.
Where can I find the shareholding pattern of Nephrocare Health Services Ltd.?
The quarterly shareholding pattern of Nephrocare Health Services Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Nephrocare Health Services Ltd. on Sharpely?
Share price data for Nephrocare Health Services Ltd. is updated as of 3 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.